Table 1:
Reported genetic polymorphisms associated with Chemotherapy-Induced Peripheral Neuropathy.
Agent | Mechanism | Gene (-SNP) | Functional Pathway | Reference |
---|---|---|---|---|
Platinum | Interfere with tumor cell proliferation by forming DNA-platinum adducts that accumulate in the DRG and in peripheral neurons.10,13 |
ERCC1 | DNA repair | 13,27 |
ERCC 2 | DNA repair | 28–30 | ||
XRCC1 | Cell cycle progression, RNA transcription, DNA repair, and possibly repair after platinum induced damage to DRG |
31,32 | ||
CCNH | Oxidative damage protection | 33 | ||
GPX7 | Transporter enzyme | 33 | ||
ABCC4 | Glutathione | 33 | ||
Taxanes Paclitaxel |
Stabilization of microtubules and inhibition of depolymerization, forming abnormal microtubule bundles in the cytoplasm and producing mitotic spindle disruption and apoptosis.34 |
CYP2C8 | Metabolizes paclitaxel | 37–41 |
ABCB1 | Cellular and systemic drug efflux transporter | 41–44 | ||
TUBB2A | Molecular target for paclitaxel | 44,45 | ||
FGD4 | Myelin production | 51 | ||
EPHA4,5,6 | Nervous system development / repair | 41,45, 53–55 | ||
ARHGEF10 | Neurodevelopment | 58,59 | ||
Docetaxel | ABCB1 | Cellular and systemic drug efflux transporter | 65–67 | |
GSTP1 | Drug conjugation and detoxification | 66,68 69 | ||
VAC14 | Neurodevelopment | 71–74 | ||
Vinca Alkaloids | Promote disassembly of microtubules by binding to tubulin during S phase and preventing microtubule polymerization, disrupting mitotic spindle formation in M phase and rendering cell unable to divide.74 |
CEP72 | Microtubule formation | 75–79 |
CYP3A5 | Vincristine metabolism | 80−89 | ||
Bortezomib | Indirectly polymerize tubulin, causing microtubule stabilization, axonal transport inhibition and G2-M phase cell cycle arrest.93 |
CTLA4 rs4553808 | Immune function | 94 |
PSMB1 rs1474642 | Drug binding | 94 | ||
PKNOX1–21q22.3 | Severe bortezomib-IPN | 96 | ||
CDH13, DCC, TENM3: 4q34.3-rs6552496, 5q14.1- rs12521798, 16q23.3- rs8060632, 18q21.2- rs17748074 |
Unknown: Intergenic |
95 |
||
Thalidomide | Inhibit production of IL-6 (growth factor), blocks the cell growth-stimulating CD147/MCT1 protein complex from binding to Cereblon, activate apoptotic pathways through caspase 8-mediated cell death, and activates T cells to produce IL-2 augmenting NK-dependent cytotoxicity.97,101 |
ABCA1 | Neuroinflammation, neurodegeneration | 98,100 |
ICAM1 | Myelinogenesis, nerve regeneration | 98,100 | ||
PPARD | Promote mitochondrial biogenesis | 98,100 | ||
SERPINB2 | Proteostasis, neuro-cytoprotection | 98, 100 | ||
SLC12A6 | K & Cl cotransporter | 98, 100 | ||
GSTT1 | Drug conjugation and detoxification | 99 |